Literature DB >> 18599598

NAD(P)H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo.

Xiaosun Zhou1, H Glenn Bohlen, Steven J Miller, Joseph L Unthank.   

Abstract

Nitric oxide (NO) and reactive oxygen species (ROS) have fundamentally important roles in the regulation of vascular tone and remodeling. Although arterial disease and endothelial dysfunction alter NO and ROS levels to impact vasodilation and vascular structure, direct measurements of these reactive species under in vivo conditions with flow alterations are unavailable. In this study, in vivo measurements of NO and H2O2 were made on mesenteric arteries to determine whether antioxidant therapies could restore normal NO production in spontaneously hypertensive rats (SHR). Flow was altered from approximately 50-200% of control in anesthetized Wistar-Kyoto rats (WKY) and SHR by selective placement of microvascular clamps on adjacent arteries while NO and H2O2 were directly measured with microelectrodes. Relative to WKY, SHR had significantly increased baseline NO and H2O2 concentrations (2,572 +/- 241 vs. 1,059 +/- 160 nM, P < 0.01; and 26 +/- 7 vs. 7 +/- 1 microM, P < 0.05, respectively). With flow elevation, H2O2 but not NO increased in SHR; NO but not H2O2 was elevated in WKY. Apocynin and polyethylene-glycolated catalase decreased baseline SHR NO and H2O2 to WKY levels and restored flow-mediated NO production. Suppression of NAD(P)H oxidase with gp91ds-tat decreased SHR H2O2 to WKY levels. Addition of topical H2O2 to increase peroxide to the basal concentration measured in SHR elevated WKY NO to levels observed in SHR. The results support the hypothesis that increased vascular peroxide in SHR is primarily derived from NAD(P)H oxidase and increases NO concentration to levels that cannot be further elevated with increased flow. Short-term and even acute administration of antioxidants are able to restore normal flow-mediated NO signaling in young SHR.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599598      PMCID: PMC2544510          DOI: 10.1152/ajpheart.00114.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  74 in total

1.  Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery.

Authors:  N Gokce; M Holbrook; S J Duffy; S Demissie; L A Cupples; E Biegelsen; J F Keaney; J Loscalzo; J A Vita
Journal:  Hypertension       Date:  2001-12-01       Impact factor: 10.190

2.  Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway.

Authors:  Shane R Thomas; Kai Chen; John F Keaney
Journal:  J Biol Chem       Date:  2001-12-13       Impact factor: 5.157

3.  Intestinal absorption of sodium and nitric oxide-dependent vasodilation interact to dominate resting vascular resistance.

Authors:  H G Bohlen; J M Lash
Journal:  Circ Res       Date:  1996-02       Impact factor: 17.367

4.  Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries.

Authors:  Tetsuya Matoba; Hiroaki Shimokawa; Hiroshi Kubota; Keiko Morikawa; Takako Fujiki; Ikuko Kunihiro; Yasushi Mukai; Yoji Hirakawa; Akira Takeshita
Journal:  Biochem Biophys Res Commun       Date:  2002-01-25       Impact factor: 3.575

5.  Ramipril improves hemodynamic recovery but not microvascular response to ischemia in spontaneously hypertensive rats.

Authors:  Costanza Emanueli; Maria Bonaria Salis; Tiziana Stacca; Alessandra Pinna; Leonardo Gaspa; Alessandra Spano; Paolo Madeddu
Journal:  Am J Hypertens       Date:  2002-05       Impact factor: 2.689

6.  Increased basal nitric oxide release despite enhanced free radical production in hypertension.

Authors:  Angelo Maffei; Roberta Poulet; Carmine Vecchione; Salvatore Colella; Luigi Fratta; Giacomo Frati; Valentina Trimarco; Bruno Trimarco; Giuseppe Lembo
Journal:  J Hypertens       Date:  2002-06       Impact factor: 4.844

7.  Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide.

Authors:  M Kelm; M Feelisch; T Krebber; A Deussen; W Motz; B E Strauer
Journal:  Hypertension       Date:  1995-02       Impact factor: 10.190

8.  Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension.

Authors:  M R Tschudi; S Mesaros; T F Lüscher; T Malinski
Journal:  Hypertension       Date:  1996-01       Impact factor: 10.190

9.  Vascular free radical release. Ex vivo and in vivo evidence for a flow-dependent endothelial mechanism.

Authors:  F R Laurindo; M de A Pedro; H V Barbeiro; F Pileggi; M H Carvalho; O Augusto; P L da Luz
Journal:  Circ Res       Date:  1994-04       Impact factor: 17.367

10.  Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension.

Authors:  E Nava; G Noll; T F Lüscher
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690

View more
  30 in total

Review 1.  Role of reactive oxygen and nitrogen species in the vascular responses to inflammation.

Authors:  Peter R Kvietys; D Neil Granger
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

2.  Resurrecting hope for antioxidant treatment of cardiovascular disease: focus on mitochondria.

Authors:  Paul M O'Connor; David D Gutterman
Journal:  Circ Res       Date:  2010-07-09       Impact factor: 17.367

3.  Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress.

Authors:  Talin Ebrahimian; Melissa Wei Li; Catherine A Lemarié; Stefania M C Simeone; Patrick J Pagano; Matthias Gaestel; Pierre Paradis; Sven Wassmann; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

4.  Constitutive NADPH oxidase 4 activity resides in the composition of the B-loop and the penultimate C terminus.

Authors:  Katharina von Löhneysen; Deborah Noack; Patti Hayes; Jeffrey S Friedman; Ulla G Knaus
Journal:  J Biol Chem       Date:  2012-01-25       Impact factor: 5.157

5.  Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature.

Authors:  Maria A Potenza; Sara Gagliardi; Leonarda De Benedictis; Addolorata Zigrino; Edy Tiravanti; Giuseppe Colantuono; Antonio Federici; Loredana Lorusso; Vincenzo Benagiano; Michael J Quon; Monica Montagnani
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

6.  Transfer of nitric oxide by blood from upstream to downstream resistance vessels causes microvascular dilation.

Authors:  H G Bohlen; X Zhou; J L Unthank; S J Miller; R Bills
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

7.  Nox2 and p47(phox) modulate compensatory growth of primary collateral arteries.

Authors:  Matthew R DiStasi; Joseph L Unthank; Steven J Miller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-14       Impact factor: 4.733

8.  Impaired compensation to femoral artery ligation in diet-induced obese mice is primarily mediated via suppression of collateral growth by Nox2 and p47phox.

Authors:  Matthew R DiStasi; Julie A Mund; H Glenn Bohlen; Steven J Miller; David A Ingram; Michael C Dalsing; Joseph L Unthank
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-21       Impact factor: 4.733

9.  NAD(P)H oxidase and eNOS play differential roles in cytomegalovirus infection-induced microvascular dysfunction.

Authors:  Igor L Leskov; Jennifer Whitsett; Jeannette Vasquez-Vivar; Karen Y Stokes
Journal:  Free Radic Biol Med       Date:  2011-10-06       Impact factor: 7.376

10.  Abnormal nitric oxide production in aged rat mesenteric arteries is mediated by NAD(P)H oxidase-derived peroxide.

Authors:  Xiaosun Zhou; H Glenn Bohlen; Joseph L Unthank; Steven J Miller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-25       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.